BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 26082506)

  • 1. Beyond the NIH Multicenter HIV Transplant Trial Experience: Outcomes of HIV+ Liver Transplant Recipients Compared to HCV+ or HIV+/HCV+ Coinfected Recipients in the United States.
    Sawinski D; Goldberg DS; Blumberg E; Abt PL; Bloom RD; Forde KA
    Clin Infect Dis; 2015 Oct; 61(7):1054-62. PubMed ID: 26082506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term Outcomes After Liver Transplantation Among Human Immunodeficiency Virus-Infected Recipients.
    Locke JE; Durand C; Reed RD; MacLennan PA; Mehta S; Massie A; Nellore A; DuBay D; Segev DL
    Transplantation; 2016 Jan; 100(1):141-6. PubMed ID: 26177090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection.
    Terrault NA; Roland ME; Schiano T; Dove L; Wong MT; Poordad F; Ragni MV; Barin B; Simon D; Olthoff KM; Johnson L; Stosor V; Jayaweera D; Fung J; Sherman KE; Subramanian A; Millis JM; Slakey D; Berg CL; Carlson L; Ferrell L; Stablein DM; Odim J; Fox L; Stock PG;
    Liver Transpl; 2012 Jun; 18(6):716-26. PubMed ID: 22328294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic kidney disease after liver transplantation in human immunodeficiency virus/hepatitis C virus-coinfected recipients versus human immunodeficiency virus-infected recipients without hepatitis C virus: results from the National Institutes of Health multi-site study.
    Bahirwani R; Barin B; Olthoff K; Stock P; Murphy B; Rajender Reddy K;
    Liver Transpl; 2013 Jun; 19(6):619-26. PubMed ID: 23512786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A National Study of Outcomes among HIV-Infected Kidney Transplant Recipients.
    Locke JE; Mehta S; Reed RD; MacLennan P; Massie A; Nellore A; Durand C; Segev DL
    J Am Soc Nephrol; 2015 Sep; 26(9):2222-9. PubMed ID: 25791727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intention-to-treat survival analysis of hepatitis C virus/human immunodeficiency virus coinfected liver transplant: Is it the waiting list?
    Araiz JJ; Serrano MT; García-Gil FA; Lacruz EM; Lorente S; Sánchez JI; Suarez MA
    Liver Transpl; 2016 Sep; 22(9):1186-96. PubMed ID: 27114030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes of orthotopic liver transplantation in human immunodeficiency virus-infected patients and comparison with human immunodeficiency virus-negative cases.
    Baccarani U; Adani GL; Bragantini F; Londero A; Comuzzi C; Rossetto A; Lorenzin D; Bresadola V; Risaliti A; Pea F; Toniutto P; Donini A; De Anna D; Bresadola F; Tavio M; Viale P
    Transplant Proc; 2011 May; 43(4):1119-22. PubMed ID: 21620067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and outcome of infections in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients: a FIPSE/GESIDA prospective cohort study.
    Moreno A; Cervera C; Fortún J; Blanes M; Montejo E; Abradelo M; Len O; Rafecas A; Martín-Davila P; Torre-Cisneros J; Salcedo M; Cordero E; Lozano R; Pérez I; Rimola A; Miró JM;
    Liver Transpl; 2012 Jan; 18(1):70-81. PubMed ID: 21898772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superior outcomes in HIV-positive kidney transplant patients compared with HCV-infected or HIV/HCV-coinfected recipients.
    Sawinski D; Forde KA; Eddinger K; Troxel AB; Blumberg E; Tebas P; Abt PL; Bloom RD
    Kidney Int; 2015 Aug; 88(2):341-9. PubMed ID: 25807035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of liver transplantation for recipients with hepatitis B and hepatitis C virus coinfection: analysis of the UNOS data.
    Waki K; Sugawara Y; Tamura S; Mieno MN; Yamashiki N; Kadowaki T; Kokudo N
    Transplantation; 2011 Oct; 92(7):809-14. PubMed ID: 21832961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved Survival After Liver Transplantation for Patients With Human Immunodeficiency Virus (HIV) and HIV/Hepatitis C Virus Coinfection in the Integrase Strand Transfer Inhibitor and Direct-Acting Antiviral Eras.
    Jacob JS; Shaikh A; Goli K; Rich NE; Benhammou JN; Ahmed A; Kim D; Rana A; Goss JA; Naggie S; Lee TH; Kanwal F; Cholankeril G
    Clin Infect Dis; 2023 Feb; 76(4):592-599. PubMed ID: 36221143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
    Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes in HIV+/HCV+ coinfected kidney transplant recipients in the pre- and post-direct-acting antiviral therapy eras: 10-Year single center experience.
    Camargo JF; Anjan S; Chin-Beckford N; Morris MI; Abbo LM; Simkins J; Ciancio G; Chen LJ; Burke GW; Figueiro J; Guerra G; Kupin WL; Mattiazzi A; Ortigosa-Goggins M; Ram Bhamidimarri K; Roth D
    Clin Transplant; 2019 May; 33(5):e13532. PubMed ID: 30866102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus-HIV-coinfected patients and liver transplantation.
    Kardashian AA; Price JC
    Curr Opin Organ Transplant; 2015 Jun; 20(3):276-85. PubMed ID: 25944240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful sofosbuvir-based therapy in HIV/hepatitis C virus coinfected liver transplant recipients with recurrent hepatitis C virus infection.
    Grant JL; Hawkins C; Brooks H; Palella FJ; Koppe SW; Abecassis MM; Stosor V
    AIDS; 2016 Jan; 30(1):93-8. PubMed ID: 26731756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of diabetes and acute rejection on liver transplant outcomes: An analysis of the organ procurement and transplantation network/united network for organ sharing database.
    Kuo HT; Lum E; Martin P; Bunnapradist S
    Liver Transpl; 2016 Jun; 22(6):796-804. PubMed ID: 26850091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus.
    Duclos-Vallée JC; Féray C; Sebagh M; Teicher E; Roque-Afonso AM; Roche B; Azoulay D; Adam R; Bismuth H; Castaing D; Vittecoq D; Samuel D;
    Hepatology; 2008 Feb; 47(2):407-17. PubMed ID: 18098295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Raising HOPE": Improved Outcomes for HIV/HCV-coinfected Liver Transplant Recipients in the Direct-acting Antiviral Era.
    Cotter TG; Wang J; Lieber SR; Odenwald MA; Rich NE; Marrero JA; Singal AG; Mitchell MC; Aronsohn A; Charlton M; Fung J
    Transplant Direct; 2021 Jul; 7(7):e707. PubMed ID: 34124343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection.
    Lo Re V; Volk J; Newcomb CW; Yang YX; Freeman CP; Hennessy S; Kostman JR; Tebas P; Leonard MB; Localio AR
    Hepatology; 2012 Nov; 56(5):1688-98. PubMed ID: 22619086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of liver transplantation in HIV-infected individuals: the impact of HCV and HBV infection.
    Norris S; Taylor C; Muiesan P; Portmann BC; Knisely AS; Bowles M; Rela M; Heaton N; O'Grady JG
    Liver Transpl; 2004 Oct; 10(10):1271-8. PubMed ID: 15376307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.